Anticipated Financial Results for Cardinal Health: Key Predictions
In the healthcare sector, Cardinal Health Inc. (CAH), a Dublin, Ohio-based company operating in the Pharmaceutical and Medical segments, is gearing up for the release of its fiscal Q4 2025 earnings results on Tuesday, August 12, before the market opens [1][3][5]. Analysts predict earnings per share (EPS) of $2.03, representing a 10.3% increase from $1.84 in Q4 of the previous year [1][3][5].
The robust growth expectations are reflected in the consensus EPS estimate for the entire current fiscal year 2025, which stands at $8.20, up 8.9% from $7.53 in fiscal 2024 [1]. This forecast reflects an updated full-year adjusted EPS guidance of $8.15 to $8.20, surpassing earlier ranges and expectations [1].
The overall analyst consensus on CAH stock is strongly bullish, with 11 of 14 analysts rating it a "Strong Buy" and the remaining 3 recommending "Hold" [1]. The average analyst price target is $180.33, indicating a potential upside of about 14.8% from the current trading price of approximately $159.49 [1].
CAH has been on an upward trajectory, with its stock surging 64.6% over the past year [1]. On June 13, CAH's stock price increased by over 4% [1]. Notably, CAH has surpassed Wall Street's bottom-line estimates in each of the past four quarters [1].
With a market cap of $37.8 billion, Cardinal Health Inc. (CAH) is poised for another significant quarter, as it continues to navigate the dynamic healthcare landscape.
It is important to note that all information and data provided in this article are solely for informational purposes. Investors are encouraged to conduct their own due diligence before making any investment decisions. The article's Disclosure Policy can be viewed on the website.
[1] - Source: Yahoo Finance [3] - Source: MarketWatch [5] - Source: Seeking Alpha
Investors are keenly watching Cardinal Health Inc. (CAH) as it prepares to release its fiscal Q4 2025 earnings results, considering the strong bullish analyst consensus and expected growth in EPS. The finance sector anticipates a 10.3% increase in EPS to $2.03, and the full-year adjusted EPS guidance estimates a potential 8.9% increase from fiscal 2024. Furthermore, with a robust stock performance over the past year and consistently surpassing Wall Street's bottom-line estimates, CAH is poised for another significant quarter in the business world. As always, it is crucial for investors to conduct their due diligence before making any investment decisions.
